UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ---------------- FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Bio-Imaging Technologies, Inc. -------------------------------------------------------------------------------- (Exact Name of Registrant as Specified in Its Charter) Delaware 11-2872047 ---------------------------------------- --------------------------------- (State of Incorporation or Organization) (IRS Employer Identification No.) 826 Newtown-Yardley Road Newtown, Pennsylvania 18940 ---------------------------------------- --------------------------------- (Address of Principal Executive Offices) (Zip Code) If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box. |_| If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. |_| SECURITIES ACT REGISTRATION STATEMENT FILE NUMBER TO WHICH THIS FORM RELATES: N/A ---------------- (If applicable) SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12(B) OF THE ACT: Title of Each Class Name of Each Exchange on Which to be so Registered Each Class is to be Registered ------------------- ------------------------------ None. SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12(G) OF THE ACT: None. ---------------- (Title of Class) INFORMATION REQUIRED IN REGISTRATION STATEMENT ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED. The common stock of Bio-Imaging Technologies, Inc., a Delaware corporation (the "Company"), $0.00025 par value per share (the "Common Stock"), previously registered pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is being withdrawn from registration under Section 12(b) of the Exchange Act. The Common Stock will be registered under Section 12(g) of the Exchange Act pursuant to the registration statement on Form 8-A being filed concurrently herewith. ITEM 2. EXHIBITS. Not applicable. SIGNATURE Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized. Bio-Imaging Technologies, Inc. Date: December 16, 2003 By: /s/ Ted I. Kaminer --------------------------- Ted I. Kaminer Chief Financial Officer